Compounding Pharmacy · Southlake, TX · 503B

FarmaKeio Outsourcing Review

FarmaKeio Outsourcing is the FDA-registered 503B arm of the FarmaKeio Pharmacy Network, a Texas-based custom compounding operation that produces sterile formulations including semaglutide and tirzepatide combinations. FarmaKeio is licensed in 49 states plus Puerto Rico and the U.S. Virgin Islands and is a lead plaintiff, alongside the Outsourcing Facilities Association, in litigation challenging the FDA's removal of tirzepatide from the drug shortage list.

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

503BFDA Registered 503B
Location: Southlake, TX
Phone: (888) 501-0233
Website: farmakeio.com
States licensed: 0
7.0
Weight Loss Rankings Score
out of 10

About this pharmacy

FarmaKeio Outsourcing is the FDA-registered 503B arm of the FarmaKeio Pharmacy Network, a Texas-based custom compounding operation that produces sterile formulations including semaglutide and tirzepatide combinations. FarmaKeio is licensed in 49 states plus Puerto Rico and the U.S. Virgin Islands and is a lead plaintiff, alongside the Outsourcing Facilities Association, in litigation challenging the FDA's removal of tirzepatide from the drug shortage list.

Certifications & Compliance

All sterile compounding pharmacies in the United States are required to follow United States Pharmacopeia General Chapter <797> sterile compounding standards[4], with finished preparations evaluated against USP <71> sterility testing[5] and USP <85> bacterial endotoxin testing[6] as appropriate for the product type.

FDA Registered 503B
Registered directly with the FDA as a 503B outsourcing facility. Subject to FDA inspection and required to follow cGMP standards.

Drugs Produced

Compounding pharmacies' ability to produce semaglutide or tirzepatide depends on the FDA Drug Shortage List status for each reference product; compounding eligibility can change when a drug moves on or off the shortage list[7].

Yes
Semaglutide
Compounded semaglutide produced
Yes
Tirzepatide
Compounded tirzepatide produced

States Licensed (0)

Regulatory Actions

No public FDA enforcement actions or recalls are on file in our records for FarmaKeio Outsourcing. Regulatory status can change — verify with the FDA and your state board of pharmacy before relying on this information.

Weight Loss Rankings Score Breakdown

Accreditation & Compliance6/10
Regulatory Standing9/10
State Coverage0/10
GLP-1 Production10/10
Track Record5/10

Scores are independently researched. See our methodology for details.

Medium confidence · Last verified 2026-06-04 via manual · How we verify provider data

Frequently Asked Questions

Glossary references

Key terms in this article, linked to their canonical definitions.

Sources & methodology — as of June 2026
  1. 1.FDA — Compounding and the 503A Pharmacy FrameworkU.S. Food & Drug Administration.
  2. 2.FDA — 503B Outsourcing Facility Registration and RequirementsU.S. Food & Drug Administration.
  3. 3.PCAB — Pharmacy Compounding Accreditation Board StandardsAccreditation Commission for Health Care (ACHC) / PCAB.
  4. 4.USP General Chapter <797> — Pharmaceutical Compounding: Sterile PreparationsUnited States Pharmacopeia.
  5. 5.USP General Chapter <71> — Sterility TestsUnited States Pharmacopeia.
  6. 6.USP General Chapter <85> — Bacterial Endotoxins TestUnited States Pharmacopeia.
  7. 7.FDA — Drug Shortages Database (current shortage listings)U.S. Food & Drug Administration.